Regulatory Affairs, Quality Systems, Policy, and Ethics: HOW INSTITUTIONAL BIOSAFETY COMMITTEES CONTRIBUTE TO SAFETY, CAPACITY AND REGULATORY APPROVALS IN CELL AND GENE THERAPY TRIALS

Saved in:
Bibliographic Details
Published inCytotherapy (Oxford, England) Vol. 24; no. 5; pp. S194 - S195
Main Authors O’Sullivan, G., Yu, B., Bailey, C., Velickovic, Z., Rasko, J.
Format Journal Article
LanguageEnglish
Published 01.05.2022
Online AccessGet full text

Cover

Loading…
More Information
ISSN:1465-3249
DOI:10.1016/S1465-3249(22)00495-9